BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Monday, May 6, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 22, 2006
View Archived Issues
Preclinical data on the safety of the antithrombotic drug W215A/E217A reported
Read More
HuLuc-63 to enter clinical program for multiple myeloma
Read More
Safety and pharmacodynamics of SB-559448 reported in healthy subjects
Read More
Pregabalin beneficial in patients with spinal cord injury
Read More
Snapshots: Phase I clinical studies in hematological malignancies
Read More
MedImmune and BioWa to develop inflammatory disease therapies targeting IL-5
Read More
Gynecologic Oncology Group to support phase II study of Lovaxin C
Read More
CESAR to support enrollment in phase II Davanat study
Read More
Novel temperature- and pH-sensitive vaginal gel may be useful to prevent HIV infection
Read More
Recent patents report new treatments for metabolic disorders
Read More
L- and P- selectin antagonists patented by GlycoMimetics
Read More
Recent patents impart novel therapeutic agents for musculoskeletal and connective tissue disorders
Read More
Pevion begins clinical testing of virosome-based HCV vaccine
Read More
Org-50081 begins phase III for insomnia
Read More
EPC-2407 begins phase I study for cancer
Read More
Atacicept studied in phase II for rheumatoid arthritis
Read More
Hepatitis C protease inhibitor ITMN-191 studied in phase Ia European trial
Read More
Altana shareholders approve acquisition by Nycomed
Read More
Orexo files to complete phase III program for Sublinox
Read More
RheoGene and Intrexon to merge
Read More
Exelixis files IND for XL-518
Read More
GSK begins phase II studies with collaborative CRF1 receptor antagonist
Read More
SGN-40 begins phase II trial for diffuse large B-cell lymphoma
Read More
Aztreonam lysine for inhalation meets endpoint in cystic fibrosis study
Read More
Ardana announces preliminary results in a phase II study in benign prostatic hyperplasia
Read More
Pediatric indication approved for Colazal
Read More
FDA approval for Invanz
Read More
CV Therapeutics files ranolazine for chronic angina in E.U.
Read More
Japanese approval sought for Risperdal Consta
Read More
Invega approved for treatment of schizophrenia
Read More